Artemis Medicare Services Limited

rs,

Complex, Bandra (E), Mumbai – 400 051 Listing Department, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001 NSE Symbol: ARTEMISMED Scrip Code: 542919 Sub: Earnings Presen

67%

n Q1 FY2026 Artemis Hospitals : At a Glance Established in July 2007 by promoters of Apollo Tyres (67% ownership), Artemis Hospital is one of the leading healthcare service providers in Delhi NCR 800+

rs 40

s, chain of asset light centres operating cardiac care centres across India 500+ Full time Doctors 40+ Specialities 12 Centres of Excellence 1100+ Bed capacity by FY26 100+ Countries 2 Consolidate

6.5%

Countries 2 Consolidated Financial Highlights – Q1 FY26 Key Financials (INR Mn) Gross Revenue 6.5% Net Revenue 6.6% EBITDA 31.9% 14.4% 2,344 2,681 9,222 9,819 14.2% 2,232 2,550 8,

6.6%

olidated Financial Highlights – Q1 FY26 Key Financials (INR Mn) Gross Revenue 6.5% Net Revenue 6.6% EBITDA 31.9% 14.4% 2,344 2,681 9,222 9,819 14.2% 2,232 2,550 8,786 9,369 19.1%

31.9%

cial Highlights – Q1 FY26 Key Financials (INR Mn) Gross Revenue 6.5% Net Revenue 6.6% EBITDA 31.9% 14.4% 2,344 2,681 9,222 9,819 14.2% 2,232 2,550 8,786 9,369 19.1% 406 483 Q

14.4%

ghlights – Q1 FY26 Key Financials (INR Mn) Gross Revenue 6.5% Net Revenue 6.6% EBITDA 31.9% 14.4% 2,344 2,681 9,222 9,819 14.2% 2,232 2,550 8,786 9,369 19.1% 406 483 Q1 FY25

14.2%

Mn) Gross Revenue 6.5% Net Revenue 6.6% EBITDA 31.9% 14.4% 2,344 2,681 9,222 9,819 14.2% 2,232 2,550 8,786 9,369 19.1% 406 483 Q1 FY25 Q1 FY26 FY24 FY25 Q1 FY25 Q1 FY26

19.1%

6.6% EBITDA 31.9% 14.4% 2,344 2,681 9,222 9,819 14.2% 2,232 2,550 8,786 9,369 19.1% 406 483 Q1 FY25 Q1 FY26 FY24 FY25 Q1 FY25 Q1 FY26 FY24 FY25 Q1 FY25 Q1 FY26 Margin:

18.2%

406 483 Q1 FY25 Q1 FY26 FY24 FY25 Q1 FY25 Q1 FY26 FY24 FY25 Q1 FY25 Q1 FY26 Margin: 18.2% 19.0% 1,401 1,848 FY24 15.9% FY25 19.7% Onkar Kanwar Chairman “We are pleased to announ

19.0%

483 Q1 FY25 Q1 FY26 FY24 FY25 Q1 FY25 Q1 FY26 FY24 FY25 Q1 FY25 Q1 FY26 Margin: 18.2% 19.0% 1,401 1,848 FY24 15.9% FY25 19.7% Onkar Kanwar Chairman “We are pleased to announce a st

15.9%

FY25 Q1 FY25 Q1 FY26 FY24 FY25 Q1 FY25 Q1 FY26 Margin: 18.2% 19.0% 1,401 1,848 FY24 15.9% FY25 19.7% Onkar Kanwar Chairman “We are pleased to announce a strong start to FY26, with Q1 d

“18.2% 19.0% 1,401 1,848 FY24 15.9% FY25 19.7% Onkar Kanwar Chairman “We are pleased to announce a strong start to FY26, with Q1 delivering consistent growth and resilient operational performance despite being a seasonally soft quarter.”

“Operational Census Beds Occupancy % ALOS Q1 FY26 INR 83,900 98,542 FY25 INR 80,200 381,968 4,040 13,761 543 489 61.2% 64.1% 3.7 3.6 Note: Average length of stay (ALOS), Average gross revenue per occupied bed (ARPOB) 7 Artemis Hospital Gurgaon Gross Revenue Annual Performance Trend Quarterly Performance Trend 7,278 8,524 9,171 2,189 2,364 (INR Mn) Key Highlights Reported 12.3% revenue CAGR and 34.0% EBITDA 2,535 CAGR during FY23-25.”

“Operational Census Beds (Nos.) Occupancy Rate (%) ARPOB (INR) 522 543 456 66.6% 60.8% 61.2% 79,200 82,800 83,900 Q1 FY25 Q4 FY25 Q1 FY26 Q1 FY25 Q4 FY25 Q1 FY26 Q1 FY25 Q4 FY25 Q1 FY26 Patient Volumes (Nos.) Surgeries Performed (Nos.) ALOS (Days) 97,049 93,443 98,542 3,708 4,040 3,340 3.6 3.6 3.7 Q1 FY25 Q4 FY25 Q1 FY26 Q1 FY25 Q4 FY25 Q1 FY26 Q1 FY25 Q4 FY25 Q1 FY26 14 FY25 Operational Performance - Artemis Gurgaon Avg.”

“EBITDA Includes Other Income Margins calculated on Net Revenue from Operations 1,848 19.7% FY25 Quarterly Performance Trend 406 18.2% 482 483 20.1% 19.0% Q1 FY25 Q4 FY25 Q1 FY26 17 Q1 FY26 Financial Performance (Consolidated) Particulars (INR Mn) Gross Revenue Net Revenue from Operations Other Income Total Income Operative Expenses Employee Benefit Expenses Other expenses EBITDA EBITDA Margin Depreciation and amortisation expenses EBIT EBIT Margin Finance Cost PBT Total tax PAT PAT Margin”

Note

5

Margin

1

Margin

18.2% 19.0% 1,401 1,848 FY24 15.9% FY25 19.7% Onkar Kanwar Chairman “We are pleased to announce a strong start to FY26, with Q1 delivering consistent growth and resilient operational performance despite being a seasonally soft quarter. Our continued focus on cost optimization, operational efficiency, and disciplined execution has enabled us to maintain healthy profitability and margins. Our highest-ever ARPOB, driven by an optimized case and payer mix and strong international patient inflow, reinforces our position as a leader in Medical Value Travel. During the quarter, we added new beds at our flagship hospital’s third tower, strengthening capacity and improving unit economics in the coming quarters. We also signed a binding MoU with Dr. Vidya Sagar Kaushalya Devi Memorial Health Centre for a proposed Medical Services Agreement, marking an important step in expanding in North India. On the clinical front, we launched India’s first private Geriatrics & Longevity Department and partner

Note

1. 2. EBITDA Includes Other Income Margins calculated on Net Revenue from Operations 3 Accreditations and Centres of Excellence Accreditations Centres of Excellence National Accreditation Board for Hospitals & Healthcare Providers Artemis Organ Transplant Centre Artemis Women and Child Centre National Accreditation Board for Hospitals & Healthcare Providers - Blood Bank / Blood Centre National Accreditation Board for Hospitals & Healthcare Providers Certified Nursing Services Artemis Minimally Invasive & Bariatric Surgery Artemis Emergency & Trauma Centre Artemis Heart Centre Artemis Cancer Centre Intertek ISO 27001 Certificate First hospital in Gurugram to receive accreditation by Joint Commission International (JCI), USA The Laboratory services accredited by NABL based on ISO 15189:2012 for a specified scope of tests National Accreditation Board for Hospitals & Healthcare Providers – Ethics Committee Artemis Gastrosciences Centres Artemis Cosmetology & Plastic Surgery Centre Artemis

Note

1. 2. EBITDA Includes Other Income Margins calculated on Net Revenue from Operations 8 Artemis Hospital Gurgaon Q1 FY26 Revenue Segmentation by Speciality Q1 FY26 Revenue Segmentation by Payor 18% 19% 20% 29% 3% 3% 3% 3% 3% 4% 15% 18% 4% 9% 16% 33% Oncology Cardiology Nephrology Liver Transplant Neuro Internal Medicine Gastroentrology Obs & Gynae Orthopaedics General surgery Pulmonology Other Specialities International Patients Domestic Cash Patients Insured Patients Government Schemes 9 Artemis Hospital Gurgaon FY25 Revenue Segmentation by Speciality FY25 Revenue Segmentation by Payor 17% 20% 19% 29% 16% 19% 2% 3% 3% 3% 3% 4% 6% 9% 14% 33% Oncology Cardiology Nephrology Liver Transplant Neuro Internal Medicine Gastroentrology Obs & Gynae Orthopaedics General surgery Pulmonology Other Specialities International Patients Domestic Cash Patients Insured Patients Government Schemes 10 Artemis’ Ventures Overview Artemis Lite • Friendly neighborhood multi speciality hospitals, designed to fi

Note

1. 2. EBITDA Includes Other Income Margins calculated on Net Revenue from Operations 1,848 19.7% FY25 Quarterly Performance Trend 406 18.2% 482 483 20.1% 19.0% Q1 FY25 Q4 FY25 Q1 FY26 17 Q1 FY26 Financial Performance (Consolidated) Particulars (INR Mn) Gross Revenue Net Revenue from Operations Other Income Total Income Operative Expenses Employee Benefit Expenses Other expenses EBITDA EBITDA Margin Depreciation and amortisation expenses EBIT EBIT Margin Finance Cost PBT Total tax PAT PAT Margin

Note

1. 2. EBITDA Includes Other Income Margins calculated on Net Revenue from Operations Q1 FY26 Q1 FY25 2,681 2,550 69 2,619 1,573 384 179 483 19.0% 112 372 14.6% 74 298 86 212 8.3% 2,344 2,232 44 2,276 1,340 359 172 406 18.2% 108 298 13.3% 81 216 51 165 7.4% YoY% 14.4% 14.2% 57.3% 15.1% 17.4% 7.0% 4.1% 19.1% 3.3% 24.8% -9.2% 37.6% 67.9% 28.2% Q4 FY25 2,521 2,399 123 2,522 1,459 391 189 482 20.1% 117 365 15.2% 78 287 57 229 9.6% QoQ% 6.3% 6.3% -43.9% 3.8% 7.8% -1.9% -5.5% 0.2% -5.0% 1.8% -5.7% 3.9% 49.6% -7.5% FY25 9,819 9,369 330 9,699 5,652 1,484 715 1,848 19.7% 452 1,396 14.9% 319 1,077 255 822 8.8% 18 Q1 FY26 Financial Performance (Standalone) Particulars (INR Mn) Gross Revenue Net Revenue from Operations Other Income Total Income Operative Expenses Employee Benefit Expenses Other expenses EBITDA EBITDA Margin Depreciation and amortisation expenses EBIT EBIT Margin Finance Cost PBT Total tax PAT PAT Margin

Note

1. 2. EBITDA Includes Other Income Margins calculated on Net Revenue from Operations Q1 FY26 Q1 FY25 2,625 2,498 70 2,568 1,544 373 172 478 19.1% 107 372 14.9% 71 301 86 214 8.6% 2,280 2,169 44 2,213 1,303 347 163 401 18.5% 102 298 13.8% 77 221 52 169 7.8% YoY% 15.2% 15.2% 58.8% 16.0% 18.5% 7.7% 5.6% 19.4% 4.3% 24.6% -7.7% 35.8% 65.7% 26.6% Q4 FY25 2,466 2,348 122 2,470 1,430 380 183 478 20.3% 112 365 15.6% 75 290 58 232 9.9% QoQ% 6.5% 6.4% -43.1% 3.9% 8.0% -1.8% -6.1% 0.1% -5.2% 1.8% -5.6% 3.7% 49.3% -7.7% FY25 9,574 9,133 329 9,462 5,516 1,437 681 1,828 20.0% 430 1,397 15.3% 305 1,093 258 835 9.1% 19 Disclosure This presentation contains statements that contain “forward looking statements” including, but without limitation, statements relating to the implementation of strategic initiatives, and other statements relating to Artemis Medicare Services future business developments and economic performance. While these forward looking statements indicate our assessment and future expectat